Perspective Therapeutics (CATX)

• Market cap: $224M
• 1 day: -3.22%
• 5 days: -39.92%
• 1 month: -8.79%
• 3 months: -30%
• 6 months: 40.65%
• Year to date: -9.06%
• 1 year: -75.71%
• 5 years: -21.61%
• 10 years: -78.8%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Employees: 140